MLN0128, an investigational selective TORC1/2 kinase inhibitor, demonstrates potent antitumor activity in preclinical models of soft tissue sarcoma Meeting Abstract


Authors: Patwardhan, P.; Deraje Vasudeva, S.; Tap, W. D.; de Stanchina, E.; Schwartz, G. K.
Abstract Title: MLN0128, an investigational selective TORC1/2 kinase inhibitor, demonstrates potent antitumor activity in preclinical models of soft tissue sarcoma
Meeting Title: 104th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 73
Issue: 8 Suppl.
Meeting Dates: 2013 Apr 6-10
Meeting Location: Washington, DC
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2013-04-15
Language: English
ACCESSION: BCI:BCI201400247669
DOI: 10.1156/1538-7445.am2013-3255
PROVIDER: biosis
Notes: Meeting Abstract: 3255 -- 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- Washington, DC, USA -- April 06 -10, 2013 -- Amer Assoc Canc Res -- 0 -- Source: Biosis
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. William Douglas Tap
    378 Tap